Terms: = Breast cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2
161 results:
1. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, hk2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
2. The effect and mechanism of hexokinase-2 on cisplatin resistance in lung cancer cells A549.
Xie S; Li X; Zhao J; Zhang F; Shu Z; Cheng H; Liu S; Shi S
Environ Toxicol; 2024 May; 39(5):2667-2680. PubMed ID: 38224486
[TBL] [Abstract] [Full Text] [Related]
3. A bis-quinoline ruthenium(II) arene complex with submicromolar cytotoxicity in castration-resistant prostate cancer cells.
Khan TA; Bhar K; Samanta R; Bhatt S; Singh M; Rani R; Kumar V; Sharma AK
Chem Commun (Camb); 2024 Feb; 60(12):1579-1582. PubMed ID: 38224119
[TBL] [Abstract] [Full Text] [Related]
4. The Apoptotic and Anti-Warburg Effects of Brassinin in PC-3 Cells via Reactive Oxygen Species Production and the Inhibition of the c-Myc, SIRT1, and β-Catenin Signaling Axis.
Kwon HH; Ahn CH; Lee HJ; Sim DY; Park JE; Park SY; Kim B; Shim BS; Kim SH
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762214
[TBL] [Abstract] [Full Text] [Related]
5. Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway-A translational study.
Chang WT; Wu CC; Liao IC; Lin YW; Chen YC; Ho CH; Lee WC; Lin YC; Chen ZC; Shih JY; Wu NC; Kan WC
Free Radic Biol Med; 2023 Nov; 208():103-111. PubMed ID: 37549754
[TBL] [Abstract] [Full Text] [Related]
6. Glycolytic enzyme hk2 promotes PD-L1 expression and breast cancer cell immune evasion.
Lin J; Fang W; Xiang Z; Wang Q; Cheng H; Chen S; Fang J; Liu J; Wang Q; Lu Z; Ma L
Front Immunol; 2023; 14():1189953. PubMed ID: 37377974
[TBL] [Abstract] [Full Text] [Related]
7. Degradation of Hexokinase 2 Blocks Glycolysis and Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death for breast cancer Therapy.
Sang R; Fan R; Deng A; Gou J; Lin R; Zhao T; Hai Y; Song J; Liu Y; Qi B; Du G; Cheng M; Wei G
J Med Chem; 2023 Jul; 66(13):8464-8483. PubMed ID: 37376788
[TBL] [Abstract] [Full Text] [Related]
8. Silencing of circUSPL1 represses breast cancer progression by targeting miR-1296-5p/MTA1 axis.
Wang P; Qu H; Wang L; Hu Z
Thorac Cancer; 2023 Aug; 14(22):2198-2209. PubMed ID: 37349877
[TBL] [Abstract] [Full Text] [Related]
9. Gene Expression Profiling of Fibroepithelial Lesions of the breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract] [Full Text] [Related]
10. ErbB2-upregulated HK1 and hk2 promote breast cancer cell proliferation, migration and invasion.
Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
[TBL] [Abstract] [Full Text] [Related]
11. Chaperone-mediated autophagy promotes breast cancer angiogenesis via regulation of aerobic glycolysis.
Chen R; Li P; Fu Y; Wu Z; Xu L; Wang J; Chen S; Yang M; Peng B; Yang Y; Zhang H; Han Q; Li S
PLoS One; 2023; 18(3):e0281577. PubMed ID: 36913368
[TBL] [Abstract] [Full Text] [Related]
12. Coenzyme Q
Yang HL; Lin PY; Vadivalagan C; Lin YA; Lin KY; Hseu YC
Arch Toxicol; 2023 Apr; 97(4):1047-1068. PubMed ID: 36847822
[TBL] [Abstract] [Full Text] [Related]
13. LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer.
Liu B; Qu X; Wang J; Xu L; Zhang L; Xu B; Su J; Bian X
Exp Cell Res; 2023 Apr; 425(1):113514. PubMed ID: 36804531
[TBL] [Abstract] [Full Text] [Related]
14. Metabolic heterogeneity in early-stage lung adenocarcinoma revealed by RNA-seq and scRNA-seq.
Zhang Y; Shi J; Luo J; Liu C; Zhu L
Clin Transl Oncol; 2023 Jun; 25(6):1844-1855. PubMed ID: 36692643
[TBL] [Abstract] [Full Text] [Related]
15. Apoptosis promoting activity of selected plant steroid in MRMT-1 breast cancer cell line by modulating mitochondrial permeation pathway.
Aslam M; Augustine S; Ann Mathew A; Kanthlal SK; Panonummal R
Steroids; 2023 Feb; 190():109151. PubMed ID: 36455654
[TBL] [Abstract] [Full Text] [Related]
16. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
He J; Dong C; Zhang H; Jiang Y; Liu T; Man X
Cell Signal; 2023 Feb; 102():110527. PubMed ID: 36410635
[TBL] [Abstract] [Full Text] [Related]
17. A pan-cancer analysis of the role of hexokinase II (hk2) in human tumors.
Li R; Mei S; Ding Q; Wang Q; Yu L; Zi F
Sci Rep; 2022 Nov; 12(1):18807. PubMed ID: 36335239
[TBL] [Abstract] [Full Text] [Related]
18. Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway.
Liu C; Li S; Zhang X; Jin C; Zhao B; Li L; Miao QR; Jin Y; Fan Z
Cancer Gene Ther; 2023 May; 30(5):647-658. PubMed ID: 36241702
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Pathogenesis of Colorectal cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive
Yasudome R; Seki N; Asai S; Goto Y; Kita Y; Hozaka Y; Wada M; Tanabe K; Idichi T; Mori S; Ohtsuka T
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232922
[TBL] [Abstract] [Full Text] [Related]
20. BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect
Liu X; Liu H; Zeng L; Lv Y
PeerJ; 2022; 10():e14052. PubMed ID: 36193432
[TBL] [Abstract] [Full Text] [Related]
[Next]
